HIF-2α: Many cancers, one engine?

Cell Cycle

Volumn 9, Issue 5, 2010, Pages 859-860

  Franovic, Aleksandra ^a   Lee, Stephen ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 2ALPHA; K RAS PROTEIN; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR ALPHA; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1;

CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; EDITORIAL; ENZYME ACTIVATION; GENE MUTATION; HUMAN; KIDNEY CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; GENETICS; KIDNEY TUMOR; METABOLISM; NEOPLASM;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 77953490088     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.5.11183     Document Type: Editorial

References (10)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
2. Kaiser J. CANCER GENETICS: A detailed genetic portrait of the deadliest human cancers. Science 2008; 321:1280-1.
3. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10:789-99.
4. Sporn M, Roberts A. Autocrine growth factors and cancer. Nature 1985; 313:745-7.
5. de Paulsen N, Brychzy A, Fournier MC, Klausner RD, Gnarra JR, Pause A, Lee S. Role of transforming growth factor-alpha in von Hippel-Lindau (VHL) (-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc Natl Acad Sci USA 2001; 98:1387-92.
6. -/- renal cancer. Cancer Res 2005; 65:5221-30.
7. Kaelin WG. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2002; 2:673-82.
8. Franovic A, Holterman CE, Payette J, Lee S. Human cancers converge at the HIF-2α oncogenic axis. Proc Natl Acad Sci USA 2009; 106:21306-11.
9. Qing G, Simon MC. Hypoxia inducible factor-2a: a critical mediator of aggressive tumor phenotypes. Curr Opin Genet Dev 2009; 19:60-6.
10. Semenza G. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3:721-32.